1. |
李玉民, 石斌, 柴琛, 等. 甘肃省河西地区胃癌发病状况的调查 [J] . 中华普通外科杂志, 2004; 19(3): 183.
|
2. |
张毅. 抑癌基因失活在多原发性恶性肿瘤发生中的意义 [J] . 中国普外基础与临床杂志, 2000; 7(6): 418.
|
3. |
Mendoza-Rodríguez CA, Cerbón MA. Tumor suppressor gene p53: mechanisms of action in cell proliferation and death [J] . Rev Invest Clin, 2001; 53(3): 266.
|
4. |
赵仲堂主编. 流行病学研究方法与应用 [M] . 第1版. 北京: 科学出版社, 2000: 523~542.
|
5. |
朱新勇, 张同全, 王福春, 等. p53、 bcl-2和nm23基因在胃癌组织中的表达及其临床意义 [J] . 中国普外基础与临床杂志, 2003; 10(6): 589.
|
6. |
Feng Z, Hu W, Teresky AK, et al . Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations [J] . Proc Nat Acad Sci, 2007; 104(42): 16633.
|
7. |
Ventura A, Kirsch DG, McLaughlin ME, et al . Restoration of p53 function leads to tumour regression in vivo [J] . Nature, 2007; 445(7128): 661.
|
8. |
Hu Y, McDermott MP, Ahrendt SA. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer [J] . Clin Cancer Res, 2005; 11(7): 2502.
|
9. |
Han JY, Lee GK, Jang DH, et al . Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer [J] . Cancer, 2008; 113(4) ∶799.
|
10. |
Lee JM, Shun CT, Wu MT, et al . The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer [J] . Mutat Res, 2006; 594(1-2):181.
|
11. |
Zhu ZZ, Cong WM, Liu SF, et al . Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population [J] . World J Gastroenterol, 2005; 11(2):289.
|
12. |
Yoon YJ, Chang HY, Ahn SH, et al . MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection [J] . Carcinogenesis, 2008; 29(6): 1192.
|
13. |
Santos AM, Sousa H, Pinto D, et al . Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer [J] . Eur J Cancer, 2006; 42(7): 958.
|
14. |
Damin AP, Frazzon AP, Damin DC, et al . Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk [J] . Cancer Detect Prev, 2006; 30(6):523.
|
15. |
Gochhait S, Bukhari SI, Bairwa N, et al . Implication of BRCA 2-26G >A 5′ untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism [J] . Breast Cancer Res, 2007; 9(5) ∶R71.
|
16. |
Jones JS, Chi X, Gu X, et al . p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population [J] . Clin Cancer Res, 2004; 10(17):5845.
|
17. |
Crew KD, Neugut AI. Epiclemiology of upper gastrointestinal malignancies [J] . Semin Oncol, 2004; 31(4):450.
|
18. |
Forman D, Newell DG, Fullerton F, et al . Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation [J] . BMJ, 1991; 302(6788):1302.
|
19. |
Mitsuhashi J, Mitomi H, Tanabe S, et al . Differences in clinicopathological findings, cell kinetics and p53 expression between early gastric cancers with and without Helicobacter pylori infection [J] . Hepatogastroenterology, 2004; 51(60):1636.
|
20. |
Wang J, Chi DS, Kalin GB, et al . Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions [J] . Dig Dis Sci, 2002; 47(1):107.
|
21. |
童明宏, 孙晨光. 幽门螺杆菌感染、 p53基因突变与胃癌的相关性研究 [J] . 实用肿瘤杂志, 2003; 18(5):393.
|